Literature DB >> 33754062

N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization.

Chen Chen1,2,3, Weitang Yuan1, Quanbo Zhou1, Bo Shao1,3, Yuying Guo1,3, Weiwei Wang4, Shuaixi Yang1,3, Yaxin Guo5,6,3, Luyang Zhao5,6,3, Qin Dang1,3, Xiuxiu Yang1,3, Guixian Wang1, Qiaozhen Kang2, Zhenyu Ji5,6, Jinbo Liu1, Zhenqiang Sun1,3.   

Abstract

Tumor metastasis is the leading cause of death in patients with colorectal cancer (CRC). Circular RNAs (circRNAs) have been shown to be involved in cancer progression. However, the regulatory mechanisms of circRNAs involved in CRC tumor metastasis are currently unknown.
Methods: High-throughput sequencing was performed on 6 pairs of CRC and adjacent normal tissues to identify the expression profiles of mRNA and circRNA. circ1662 was assessed by RNA-ISH and IHC of a tissue chip. The function of circ1662 in CRC was evaluated by knocking down or overexpressing circ1662. MeRIP-qPCR, RIP-qPCR, and RNA pull-down were performed to determine the relationship between METTL3, circ1662, and YAP1.
Results: A novel circRNA, circ1662, exhibited significantly higher expression in CRC tissues than paired normal tissues. High circ1662 expression was correlated with poor prognosis and tumor depth in patients with CRC. Functionally, circ1662 promoted CRC cell invasion and migration by controlling EMT in vitro and in vivo. Mechanistically, circ1662 directly bound to YAP1 and accelerated its nuclear accumulation to regulate the SMAD3 pathway. Additionally, circ1662 enhanced CRC invasion and migration depending on YAP1 and SMAD3. Interestingly, METTL3 induced circ1662 expression by binding its flanking sequences and installing m6A modifications. Clinically, circ1662 expression strongly correlated with METTL3 and YAP1 protein expression. Moreover, YAP1 expression was negatively correlated with SMAD3 expression. Conclusions: METTL3-induced circ1662 promoted CRC cell invasion and migration by accelerating YAP1 nuclear transport. This result implies that circ1662 is a new prognostic and therapeutic marker for CRC metastasis. © The author(s).

Entities:  

Keywords:  METTL3; N6-methyladenosine (m6A); YAP1; circ1662; colorectal cancer

Mesh:

Substances:

Year:  2021        PMID: 33754062      PMCID: PMC7977475          DOI: 10.7150/thno.51342

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


  44 in total

Review 1.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

Review 2.  The Biogenesis, Functions, and Challenges of Circular RNAs.

Authors:  Xiang Li; Li Yang; Ling-Ling Chen
Journal:  Mol Cell       Date:  2018-07-26       Impact factor: 17.970

Review 3.  Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.

Authors:  Xin Ye; Robert A Weinberg
Journal:  Trends Cell Biol       Date:  2015-10-01       Impact factor: 20.808

4.  Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity.

Authors:  William W Du; Ling Fang; Weining Yang; Nan Wu; Faryal Mehwish Awan; Zhenguo Yang; Burton B Yang
Journal:  Cell Death Differ       Date:  2016-11-25       Impact factor: 15.828

5.  Transient N-6-Methyladenosine Transcriptome Sequencing Reveals a Regulatory Role of m6A in Splicing Efficiency.

Authors:  Annita Louloupi; Evgenia Ntini; Thomas Conrad; Ulf Andersson Vang Ørom
Journal:  Cell Rep       Date:  2018-06-19       Impact factor: 9.423

6.  HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events.

Authors:  Claudio R Alarcón; Hani Goodarzi; Hyeseung Lee; Xuhang Liu; Saeed Tavazoie; Sohail F Tavazoie
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

7.  NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin.

Authors:  Francois Lehembre; Mahmut Yilmaz; Andreas Wicki; Tibor Schomber; Karin Strittmatter; Dominik Ziegler; Angelika Kren; Phillip Went; Patrick W B Derksen; Anton Berns; Jos Jonkers; Gerhard Christofori
Journal:  EMBO J       Date:  2008-09-04       Impact factor: 11.598

8.  Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma.

Authors:  Jing Meng; Shuang Chen; Jing-Xia Han; Baoxin Qian; Xiao-Rui Wang; Wei-Long Zhong; Yuan Qin; Heng Zhang; Wan-Feng Gao; Yue-Yang Lei; Wei Yang; Lan Yang; Chao Zhang; Hui-Juan Liu; Yan-Rong Liu; Hong-Gang Zhou; Tao Sun; Cheng Yang
Journal:  Cancer Res       Date:  2018-05-29       Impact factor: 12.701

9.  Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer.

Authors:  Michael K Wendt; Molly A Taylor; Barbara J Schiemann; William P Schiemann
Journal:  Mol Biol Cell       Date:  2011-05-25       Impact factor: 4.138

Review 10.  The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs.

Authors:  Lele Zhang; Chaofeng Hou; Chen Chen; Yaxin Guo; Weitang Yuan; Detao Yin; Jinbo Liu; Zhenqiang Sun
Journal:  Mol Cancer       Date:  2020-06-10       Impact factor: 27.401

View more
  30 in total

Review 1.  The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer.

Authors:  Haiyan Qiao; Linfeng Liu; Jun Chen; Bingbing Shang; Liang Wang
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

2.  The Alteration Profiles of m6A-Tagged circRNAs in the Peri-Infarct Cortex After Cerebral Ischemia in Mice.

Authors:  Yudi Li; Hanzhao Li; Yang Luo; Xiaoqiang Li; Zhefeng Chen; Wanzhou Zhang; Fangming Li; Li Ling
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

Review 3.  The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms.

Authors:  Yirao Zhang; Yang Wang; Hao Ji; Jie Ding; Keming Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-06-14

Review 4.  The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer.

Authors:  Lin Luo; Yingwei Zhen; Dazhao Peng; Cheng Wei; Xiaoyang Zhang; Xianzhi Liu; Lei Han; Zhenyu Zhang
Journal:  Cell Death Discov       Date:  2022-07-18

Review 5.  Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.

Authors:  Hong Lin; Yuxi Wang; Pinghan Wang; Fangyi Long; Ting Wang
Journal:  Mol Cancer       Date:  2022-07-18       Impact factor: 41.444

Review 6.  m6A-modified circRNAs: detections, mechanisms, and prospects in cancers.

Authors:  Shiyi Qin; Qi Zhang; Yanhua Xu; Shuo Ma; Tianyi Wang; Yuejiao Huang; Shaoqing Ju
Journal:  Mol Med       Date:  2022-07-14       Impact factor: 6.376

7.  CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m6A-modified CREB1 mRNA.

Authors:  Bing Yao; Qinglin Zhang; Zhou Yang; Fangmei An; He Nie; Hui Wang; Cheng Yang; Jing Sun; Ke Chen; Jingwan Zhou; Bing Bai; Shouyong Gu; Wei Zhao; Qiang Zhan
Journal:  Mol Cancer       Date:  2022-06-30       Impact factor: 41.444

Review 8.  N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.

Authors:  Yiling Ge; Tong Liu; Chuntao Wang; Yanqiu Zhang; Siyi Xu; Yiyi Ren; Yanlu Feng; Lihong Yin; Yuepu Pu; Geyu Liang
Journal:  RNA Biol       Date:  2021-10-21       Impact factor: 4.766

9.  METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.

Authors:  Jiashu Pan; Feng Liu; Xiaoli Xiao; Ruohui Xu; Liang Dai; Mingzhe Zhu; Hanchen Xu; Yangxian Xu; Aiguang Zhao; Wenjun Zhou; Yanqi Dang; Guang Ji
Journal:  J Exp Clin Cancer Res       Date:  2022-01-10

Review 10.  Roles of circular RNAs in colorectal cancer.

Authors:  Mingying Zhang; Shubin Wang
Journal:  Oncol Lett       Date:  2021-06-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.